Search

everythinglearnresearchcommunity

for

Search:↓

New insights into cell communication in psoriasis suggest innovative drug treatments.

Zebrafish helped find new ways to prevent drug-induced hair cell death and potential treatments for hearing loss.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Cepharanthine shows promise as a COVID-19 treatment.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

Dissolvable microneedles with Ginsenoside Rg3 can help treat hair loss by improving drug delivery and stimulating hair growth.

Use finasteride over dutasteride for hair loss; consider topical treatments and weigh risks.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Invasomes loaded with clotrimazole gel could improve drug delivery through the skin for fungal treatment.

The microneedle system shows promise for non-invasive brain drug delivery.

Valproic acid is effective but often causes side effects like weight gain and hair loss, so personalized treatment is needed.

High-dose intravenous iron therapy doesn't interfere with treatment improvements in IBD patients with iron deficiency anemia.

Minoxidil nanoparticles can potentially be a more effective treatment for hair growth than current treatments.

Bubble-based systems show promise for precise, targeted drug delivery and diagnosis, especially in cancer treatment.

Vitamin E in the diet might help protect against hair loss caused by the chemotherapy drug doxorubicin in rabbits.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

The document reviews patents on nanoparticle systems used to deliver drugs, discussing their creation, use in treatments, and commercial applications.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

Combining plant extracts with nanotechnology may improve hair loss treatments.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

OBEME effectively enhances wound healing and could be a promising carrier for skin treatments.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

HSA nanoparticles can improve tamoxifen delivery for breast cancer treatment, reducing side effects.